367 related articles for article (PubMed ID: 9371490)
1. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
[TBL] [Abstract][Full Text] [Related]
2. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
3. PTEN/MMAC1 mutations in endometrial cancers.
Risinger JI; Hayes AK; Berchuck A; Barrett JC
Cancer Res; 1997 Nov; 57(21):4736-8. PubMed ID: 9354433
[TBL] [Abstract][Full Text] [Related]
4. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
[TBL] [Abstract][Full Text] [Related]
5. Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK
Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
7. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
9. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
11. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
[TBL] [Abstract][Full Text] [Related]
12. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
[TBL] [Abstract][Full Text] [Related]
14. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR
Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749
[TBL] [Abstract][Full Text] [Related]
15. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
16. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
17. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
19. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Hong WK; Mao L
Oncogene; 1998 Oct; 17(13):1749-53. PubMed ID: 9796705
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
